[{"bbox": [87, 118, 283, 256], "category": "Picture"}, {"bbox": [606, 119, 644, 146], "category": "Page-header", "text": "EN"}, {"bbox": [327, 190, 928, 220], "category": "Section-header", "text": "**THIS ACTION IS FUNDED BY THE EUROPEAN UNION**"}, {"bbox": [567, 242, 660, 269], "category": "Section-header", "text": "**ANNEX 3**"}, {"bbox": [98, 295, 1130, 352], "category": "Text", "text": "to the Commission Implementing Decision on the financing of the annual action plan in favour of Cuba for 2022"}, {"bbox": [265, 374, 963, 444], "category": "Section-header", "text": "**Action Document for Support to Cuban biotechnological industry and investments towards Global Public Goods**"}, {"bbox": [536, 459, 717, 483], "category": "Section-header", "text": "**ANNUAL PLAN**"}, {"bbox": [96, 487, 1156, 545], "category": "Text", "text": "This document constituting the annual work programme in the Article 110 (2) of the Financial Regulation, and action plans in the meaning of Article 23 of NDICI-Global Europe Regulation."}, {"bbox": [87, 573, 287, 604], "category": "Section-header", "text": "# 1 SYNOPSIS"}, {"bbox": [146, 639, 458, 669], "category": "Section-header", "text": "## 1.1 Action Summary Table"}, {"bbox": [85, 681, 1167, 1584], "category": "Table", "text": "<table><tr><td>1. Title<br/>CRIS/OPSYS business reference Basic Act</td><td>Support to Cuban biotechnological industry and investments towards Global Public Goods<br/>CRIS n°: NDICI LA/2022/044-162 / OPSYS ACT-61520<br/>Financed under the Neighborhood, Development and International Cooperation Instrument (NDICI-Global Europe)/ Overseas Association Decision/European Instrument for International Nuclear Safety Cooperation Regulation</td></tr><tr><td>2. Team Europe Initiative</td><td>Yes : under the European Union – Latin America and Caribbean partnership on local manufacturing of vaccines, medicines and other health technologies, and strengthening health systems resilience.<br/>The contribution of Member States, International Financing Institutions and implementing agencies is to be determined.</td></tr><tr><td>3. Zone benefitting from the action</td><td>Cuba</td></tr><tr><td>4. Programming document</td><td>Multiannual Indicative Programme (MIP) — EU-Cuba Cooperation 2021-2027</td></tr><tr><td>5. Link with relevant MIP (s) objectives/expected results</td><td>This action is related to the second priority of the MIP 2021-2027 Modernisation of the Economy, by supporting the advanced Cuban biotechnological sector. Given its added value in exports and taking advantage of the presence already of some Cuban Bioindustry production plants and commercial offices in the EU, the action will contribute to open Cuban's economy and increase economic ties with Europe. Under the right conditions, there is potential for Cuban and European private sector engagement.<br/>The action, as foreseen in the EU-Cuba MIP 2021-2027, will support the development and distribution, through multilateral mechanisms such as COVAX, of safe and effective vaccines, diagnostic and therapeutic products against Covid-19 and other priority health challenges.<br/>The Action contributes to Specific objective 3 from MIP's Priority Area 2 (\"Modernisation of the economy through maximizing the potential of all economic actors in key sectors\"):</td></tr></table>"}, {"bbox": [1037, 1680, 1142, 1704], "category": "Page-footer", "text": "Page 1 of 24"}]